Drug class
Phenothiazine antipsychotic; dopamine D2 receptor antagonist
Mechanism of action
Blocks dopamine D2 receptors and also interacts with alpha-adrenergic, serotonergic, histamine H1 and muscarinic receptors, contributing to antipsychotic, sedative and antiemetic effects.
General use cases
- Treatment of psychotic disorders where authorised.
- Symptomatic management of severe nausea, vomiting or agitation in selected palliative-care settings, according to local product information.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
